Literature DB >> 7987694

Genetic heterogeneity of severe childhood autosomal recessive muscular dystrophy with adhalin (50 kDa dystrophin-associated glycoprotein) deficiency.

N B Romero1, F M Tomé, F Leturcq, F E el Kerch, K Azibi, L Bachner, R D Anderson, S L Roberds, K P Campbell, M Fardeau.   

Abstract

Severe autosomal recessive muscular dystrophy (SCARMD), McKusick n. 253700, has been originally described in North-African populations, in which significant linkage has been established with DNA markers mapping to the proximal region of the long arm of chromosome 13, without evidence for heterogeneity of the SCARMD locus in these populations. A striking feature of this disease is the isolated deficiency of adhalin, a sarcolemmal 50 kDa dystrophin-associated glycoprotein. We report a non-inbred French family with a milder progressive form of muscular dystrophy affecting subjects of both sexes. The parents are not affected suggesting an autosomal recessive transmission. In 4 siblings displaying mild to overt clinical signs of muscular dystrophy, serum creatine kinase was high, and muscle specimens showed variable degree of necrosis-regeneration with little fibrosis. In the 4 cases adhalin was completely absent in muscle sections, whereas dystrophin and the other members of the dystrophin-associated protein complex were normal, except for the 35 kDa dystrophin-associated glycoprotein which was decreased as usually observed in SCARMD. Linkage and homogeneity analysis using 4 microsatellite markers of chromosome 13q that are linked to the North-African SCARMD locus were performed in this family. Results show that the morbid locus involved in this family does not map to the same region as the SCARMD locus. This second locus may be involved in sporadic cases of muscular dystrophy with adhalin deficiency that have been reported in Europe.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7987694

Source DB:  PubMed          Journal:  C R Acad Sci III        ISSN: 0764-4469


  6 in total

1.  Main clinical features of the three mapped autosomal recessive limb-girdle muscular dystrophies and estimated proportion of each form in 13 Brazilian families.

Authors:  M R Passos-Bueno; E S Moreira; S K Marie; R Bashir; L Vasquez; D R Love; M Vainzof; P Iughetti; J R Oliveira; E Bakker; T Strachan; K Bushby; M Zatz
Journal:  J Med Genet       Date:  1996-02       Impact factor: 6.318

2.  Mutational diversity and hot spots in the alpha-sarcoglycan gene in autosomal recessive muscular dystrophy (LGMD2D).

Authors:  A Carrié; F Piccolo; F Leturcq; C de Toma; K Azibi; C Beldjord; J M Vallat; L Merlini; T Voit; C Sewry; J A Urtizberea; N Romero; F M Tomé; M Fardeau; Y Sunada; K P Campbell; J C Kaplan; M Jeanpierre
Journal:  J Med Genet       Date:  1997-06       Impact factor: 6.318

3.  Adhalin gene mutations in patients with autosomal recessive childhood onset muscular dystrophy with adhalin deficiency.

Authors:  H Kawai; M Akaike; T Endo; K Adachi; T Inui; T Mitsui; S Kashiwagi; T Fujiwara; S Okuno; S Shin
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

4.  Clinical and genetic spectrum in limb-girdle muscular dystrophy type 2E.

Authors:  Claudio Semplicini; John Vissing; Julia R Dahlqvist; Tanya Stojkovic; Luca Bello; Nanna Witting; Morten Duno; France Leturcq; Cinzia Bertolin; Paola D'Ambrosio; Bruno Eymard; Corrado Angelini; Luisa Politano; Pascal Laforêt; Elena Pegoraro
Journal:  Neurology       Date:  2015-04-10       Impact factor: 9.910

5.  LGMD. Identification, description and classification.

Authors:  Corrado Angelini
Journal:  Acta Myol       Date:  2020-12-01

6.  Combined Use of CFTR Correctors in LGMD2D Myotubes Improves Sarcoglycan Complex Recovery.

Authors:  Marcello Carotti; Martina Scano; Irene Fancello; Isabelle Richard; Giovanni Risato; Mona Bensalah; Michela Soardi; Dorianna Sandonà
Journal:  Int J Mol Sci       Date:  2020-03-06       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.